Clinical trials
Enrolling by invitation Diabetes Mellitus, Type 2 trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Novo Nordisk A/S | 1 |
| Salah Snouda | 1 |
| University of Nottingham | 1 |
| University of Ulster | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 5 |
| Cardiovascular Diseases | 2 |
| Metabolic Syndrome | 2 |
| Dwarfism, Pituitary | 1 |
| Glucose Intolerance | 1 |
| Insulin Resistance | 1 |
| Mitochondrial Diseases | 1 |
| Neoplasms | 1 |
| Prediabetic State | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.